Volume 27, Number 10—October 2021
Dispatch
Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021
Table
Characteristic | Total, no. (%) |
Acute SARS-CoV-2 infection |
||||
---|---|---|---|---|---|---|
No | Yes | Total % | p value | |||
All participants |
44 |
20 |
24 |
54.6 |
||
Mean age |
44 |
51.9 |
54.5 |
0.88 |
||
Immune status | ||||||
Fully vaccinated, 2 doses | 25 (56.8) | 10 | 15 | 60.0 | 0.20 | |
Vaccinated, 1 dose | 9 (20.5) | 3 | 6 | 66.7 | ||
History of COVID-19, vaccinated 1 dose | 3 (6.8) | 3 | 0 | 0.00 | ||
History of COVID-19, not vaccinated | 3 (6.8) | 3 | 0 | 0.00 | ||
Neither vaccinated nor history |
4 (9.1) |
1 |
3 |
75.0 |
||
History of previous COVID-19 | ||||||
Y | 6 (8.9) | 6 | 0 | 0.00 | 0.004 | |
N |
38 (86.4) |
14 |
24 |
63.2 |
||
Sex | ||||||
M | 42 (95.4) | 18 | 24 | 57.1 | 0,11 | |
F |
2 (4.5) |
2 |
0 |
0.0 |
||
Age, y | ||||||
<55 | 24 (54.5) | 11 | 12 | 52.2 | 0.74 | |
>55 |
20 (45.4) |
9 |
12 |
57.1 |
||
Country of birth | ||||||
Brazil | 34 (77.3) | 16 | 18 | 52.9 | ||
Surinam | 6 (13.6) | 2 | 4 | 66.7 | ||
Haiti | 2 (4.5) | 1 | 1 | |||
Guyana | 1 (2.3) | 0 | 1 | |||
France |
1 (2.3) |
1 |
0 |
|||
Occupation | ||||||
Laborer | 20 (45.4) | 8 | 12 | 60.0 | 0.73 | |
Operator | 17 (38.6) | 8 | 9 | 52.9 | ||
Other |
7 (15.9) |
4 |
3 |
42.9 |
||
Eat alone | ||||||
Y | 7 (15.9) | 5 | 2 | 28.6 | 0.13 | |
N |
37 (84.1) |
15 |
22 |
59.5 |
||
Live alone | ||||||
Y | 28 (63.6) | 15 | 13 | 46.4 | 0.13 | |
N |
16 (36.4) |
5 |
11 |
68.8 |
||
Contact outside the mine in the previous 2 weeks | ||||||
Y | 26 (60.5) | 10 | 16 | 61.5 | 0.35 | |
N |
17 (39.5) |
9 |
8 |
47.1 |
||
Underlying conditions | ||||||
Hypertension | 11 (25.0) | 5 | 6 | 54.6 | 1.00 | |
Diabetes | 4 (9.1) | 2 | 2 | 50.0 | 0.85 | |
Obesity | 4 (9.1) | 2 | 2 | 50,0 | 0.85 | |
Cardiac insufficiency | 3 (8.3) |
1 | 2 | 66.7 | 0.62 |
*We defined acute SARS-CoV-2 infection in participants as having a positive SARS-CoV-2 antigenic or PCR test in June 2021, symptomatic or not. Of the 24 with acute infection, 21 were symptomatic and 3 asymptomatic infections. p value indicates degree of significance. COVID-19, coronavirus disease; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
1These first authors contributed equally to this article.
Page created: July 15, 2021
Page updated: September 19, 2021
Page reviewed: September 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.